Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside
Byung-Sik Cho, Hee-Je Kim, Marina Konopleva
Korean J Intern Med. 2017;32(2):248-257. Published online 2017 Feb 21 DOI: https://doi.org/10.3904/kjim.2016.244
|
Citations to this article as recorded by
Targeting integrins in drug‐resistant acute myeloid leukaemia
Heather A. Ogana, Samantha Hurwitz, Nathan Wei, Eliana Lee, Kayla Morris, Karina Parikh, Yong‐Mi Kim
British Journal of Pharmacology.2024; 181(2): 295. CrossRef Advantages of nanomedicine over the conventional treatment in Acute myeloid leukemia
Gopalarethinam Janani, Agnishwar Girigoswami, Koyeli Girigoswami
Journal of Biomaterials Science, Polymer Edition.2024; 35(3): 415. CrossRef Multifunctional aptamer grafted targeted nano‐drugs execute molecular cross‐talks with cancer cells
Sounik Manna, Rumi Mahata, Surya K. Dey, Angsuman Das Chaudhuri, Sujata M. Choudhury
Applied Research.2024;[Epub] CrossRef Exploring the intricate cross-talk between clonal expansion and the bone marrow niche
Steven Ngo, Despoina Papazoglou, Hector Huerga Encabo, Dominique Bonnet
Frontiers in Hematology.2024;[Epub] CrossRef Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia
Li Yang, Qiang Xu, Junnan Li
Journal of the Formosan Medical Association.2024; 123(9): 992. CrossRef Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies
Enrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Gaia Stanzione, Annamaria Zimbo, Stefano Pozzi, Antonino Neri, Fortunato Morabito, Ernesto Vigna, Massimo Gentile
Expert Opinion on Investigational Drugs.2024; 33(9): 915. CrossRef Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives
Ian M. Bouligny, Keri R. Maher, Steven Grant
Blood Reviews.2023; 57: 100996. CrossRef Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling
Nicholas R. Anderson, Vipul Sheth, Hui Li, Mason W. Harris, Shaowei Qiu, David K. Crossman, Harish Kumar, Puneet Agarwal, Takashi Nagasawa, Andrew J. Paterson, Robert S. Welner, Ravi Bhatia
Leukemia.2023; 37(3): 560. CrossRef Resveratrol and Its Role in the Management of B-Cell Malignancies—A Recent Update
Dhruv Sanjay Gupta, Vaishnavi Gadi, Ginpreet Kaur, Meena Chintamaneni, Hardeep Singh Tuli, Seema Ramniwas, Gautam Sethi
Biomedicines.2023; 11(1): 221. CrossRef T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vázquez, Antonio Villaverde, Ramon Mangues, Isolda Casanova
Pharmaceutics.2023; 15(3): 727. CrossRef Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options
YiFan Zhao, RuiTing Guo, XinPing Cao, Yi Zhang, Rui Sun, WenYi Lu, MingFeng Zhao
International Immunopharmacology.2023; 121: 110396. CrossRef A comprehensive analysis of cell‐autonomous and non‐cell‐autonomous regulation of myeloid leukemic cells: The prospect of developing novel niche‐targeting therapies
Shalmali Pendse, Sayali Chavan, Vaijayanti Kale, Anuradha Vaidya
Cell Biology International.2023; 47(10): 1667. CrossRef The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
Maryam Bakhtiyari, Mahsa Liaghat, Fatemeh Aziziyan, Hooriyeh Shapourian, Sheida Yahyazadeh, Maedeh Alipour, Shaghayegh Shahveh, Fahimeh Maleki-Sheikhabadi, Hossein Halimi, Razieh Forghaniesfidvajani, Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Majid Pornour
Cell Communication and Signaling.2023;[Epub] CrossRef Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?
Saravanan Ganesan, Vikram Mathews, Neha Vyas
International Journal of Cancer.2022; 150(9): 1401. CrossRef The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies
Mahdieh Mehrpouri
European Journal of Pharmacology.2022; 920: 174831. CrossRef Circulating miR-126-3p and miR-423-5p Expression in de novo Adult Acute Myeloid Leukemia: Correlations with Response to Induction Therapy and the 2-Year Overall Survival
Faez Almohsen, Haithem A Al-Rubaie, Manal A Habib, Sherif A Nasr, Rajendra Perni, Lubab Al-Quraishi
Journal of Blood Medicine.2022; Volume 13: 83. CrossRef Bone Marrow Aging and the Leukaemia-Induced Senescence of Mesenchymal Stem/Stromal Cells: Exploring Similarities
Paola Fernanda Ruiz-Aparicio, Jean-Paul Vernot
Journal of Personalized Medicine.2022; 12(5): 716. CrossRef Leukemic stem cells as a target for eliminating acute myeloid leukemia: Gaps in translational research
Sophia K. Khaldoyanidi, Antreas Hindoyan, Anthony Stein, Marion Subklewe
Critical Reviews in Oncology/Hematology.2022; 175: 103710. CrossRef One-Chip Isolation of Drug-Resistant Acute Myeloid Leukemia Cells with CXCR4-Targeted Magnetic Fluorescent Nanoprobes
Fan Wang, Yuqi Jiang, Luhai Wang, Yi Chen, Yu Zhang, Ming Ma
Nanomaterials.2022; 12(10): 1711. CrossRef Role of chemokine systems in cancer and inflammatory diseases
Hongyi Li, Min Wu, Xia Zhao
MedComm.2022;[Epub] CrossRef A Systems Biology- and Machine Learning-Based Study to Unravel Potential Therapeutic Mechanisms of Midostaurin as a Multitarget Therapy on FLT3-Mutated AML
Marina Díaz-Beyá, María García-Fortes, Raquel Valls, Laura Artigas, Mª Teresa Gómez-Casares, Pau Montesinos, Fermín Sánchez-Guijo, Mireia Coma, Meritxell Vendranes, Joaquín Martínez-López
BioMedInformatics.2022; 2(3): 375. CrossRef The cytokine network in acute myeloid leukemia
Michela Luciano, Peter W. Krenn, Jutta Horejs-Hoeck
Frontiers in Immunology.2022;[Epub] CrossRef At the Bedside: Profiling and treating patients with CXCR4-expressing cancers
Miguel Martin, Ingrid A Mayer, Annemiek M E Walenkamp, Constantin Lapa, Michael Andreeff, Alexandra Bobirca
Journal of Leukocyte Biology.2021; 109(5): 953. CrossRef Targeted dendrimers for antagonizing the migration and viability of NALM-6 lymphoblastic leukemia cells
Chuda Chittasupho, Chaiyawat Aonsri, Witcha Imaram
Bioorganic Chemistry.2021; 107: 104601. CrossRef The CXCL12 Crossroads in Cancer Stem Cells and Their Niche
Juan Carlos López-Gil, Laura Martin-Hijano, Patrick C. Hermann, Bruno Sainz
Cancers.2021; 13(3): 469. CrossRef Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology
Daniel Royston, Adam J. Mead, Bethan Psaila
Hematology/Oncology Clinics of North America.2021; 35(2): 279. CrossRef The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy
Laura Mosteo, Joanna Storer, Kiran Batta, Emma J. Searle, Delfim Duarte, Daniel H. Wiseman
Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4
Victor Pallarès, Yáiza Núñez, Laura Sánchez-García, Aïda Falgàs, Naroa Serna, Ugutz Unzueta, Alberto Gallardo, Lorena Alba-Castellón, Patricia Álamo, Jorge Sierra, Antonio Villaverde, Esther Vázquez, Isolda Casanova, Ramon Mangues
Journal of Controlled Release.2021; 335: 117. CrossRef Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study
Jacek Pietrzak, Marek Mirowski, Rafał Świechowski, Damian Wodziński, Agnieszka Wosiak, Katarzyna Michalska, Ewa Balcerczak, Liren Qian
Journal of Oncology.2021; 2021: 1. CrossRef Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities
Eimear O'Reilly, Hojjat Alizadeh Zeinabad, Eva Szegezdi
Blood Reviews.2021; 50: 100850. CrossRef Relevance of plasma bone marrow Activin-A and CXCL-12 concentration levels as a biomarker in acute myeloid leukemia
Salah Aref, Lamiaa Ebrahim, Shaimaa El-Ashwah, Mohamed El Agdar, Mohamed Ayed
Cancer Biomarkers.2021; 32(3): 263. CrossRef Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression
L. C. Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, Tammy Stefan, Kalpana Gupta, Xuan Xu, Slim Fourati, Anne Roe, Zachary Jackson, Robert Schauner, Ashish Sharma, Banumathi Tamilselvan, Samuel Li, Marcos de Lima, Tae Hyun Hwang, Robert Balderas,
Leukemia.2021; 35(10): 2799. CrossRef In Silico Methods for the Identification of Diagnostic and Favorable Prognostic Markers in Acute Myeloid Leukemia
Hande Yılmaz, Halil Ibrahim Toy, Stephan Marquardt, Gökhan Karakülah, Can Küçük, Panagiota I. Kontou, Stella Logotheti, Athanasia Pavlopoulou
International Journal of Molecular Sciences.2021; 22(17): 9601. CrossRef A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Peyman Beigi, Mohammad Kiani, Ali Allahgholipour, Negar Goudarzi, Jamshid S. Khorashad, Anna M. Eiring
Cells.2021; 10(11): 2833. CrossRef Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model
Rong Wang, Wenli Feng, Hao Wang, Lina Wang, Xiao Yang, Feifei Yang, Yingchi Zhang, Xiaoli Liu, Dongyue Zhang, Qian Ren, Xiaoming Feng, Guoguang Zheng
Cancer Letters.2020; 469: 151. CrossRef Overexpressed microRNA‐103a‐3p inhibits acute lower‐extremity deep venous thrombosis via inhibition of CXCL12
Shaoliang Sun, Shanyi Chai, Feng Zhang, Lu Lu
IUBMB Life.2020; 72(3): 492. CrossRef CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
Ashraf Mousavi
Immunology Letters.2020; 217: 91. CrossRef Bone marrow niches in haematological malignancies
Simón Méndez-Ferrer, Dominique Bonnet, David P. Steensma, Robert P. Hasserjian, Irene M. Ghobrial, John G. Gribben, Michael Andreeff , Daniela S. Krause
Nature Reviews Cancer.2020; 20(5): 285. CrossRef DNA methylation disruption reshapes the hematopoietic differentiation landscape
Franco Izzo, Stanley C. Lee, Asaf Poran, Ronan Chaligne, Federico Gaiti, Baptiste Gross, Rekha R. Murali, Sunil D. Deochand, Chelston Ang, Philippa Wyndham Jones, Anna S. Nam, Kyu-Tae Kim, Steven Kothen-Hill, Rafael C. Schulman, Michelle Ki, Priscillia Lh
Nature Genetics.2020; 52(4): 378. CrossRef Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia
Eleni E Ladikou, Timothy Chevassut, Chris J Pepper, Andrea GS Pepper
British Journal of Haematology.2020; 189(5): 815. CrossRef An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
Victor Pallarès, Ugutz Unzueta, Aïda Falgàs, Laura Sánchez-García, Naroa Serna, Alberto Gallardo, Gordon A. Morris, Lorena Alba-Castellón, Patricia Álamo, Jorge Sierra, Antonio Villaverde, Esther Vázquez, Isolda Casanova, Ramon Mangues
Journal of Hematology & Oncology.2020;[Epub] CrossRef Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Zhaoying Fu, Jim Xiang
International Journal of Molecular Sciences.2020; 21(8): 2793. CrossRef Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders?
Julia Zinngrebe, Klaus-Michael Debatin, Pamela Fischer-Posovszky
Leukemia.2020; 34(9): 2305. CrossRef Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?
Debora Valli, Alicja M. Gruszka, Myriam Alcalay
Journal of Clinical Medicine.2020; 9(6): 1892. CrossRef The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia Shan Wang, Xiaojiao Wang, Sha Liu, Shengnan Zhang, Xudong Wei, Yongping Song, Qingsong Yin
OncoTargets and Therapy.2020; Volume 13: 6583. CrossRef Extracellular Adenine Nucleotides and Adenosine Modulate the Growth and Survival of THP-1 Leukemia Cells
Kamila Puchałowicz, Maciej Tarnowski, Marta Tkacz, Dariusz Chlubek, Patrycja Kłos, Violetta Dziedziejko
International Journal of Molecular Sciences.2020; 21(12): 4425. CrossRef Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia
Myriam L. R. Haltalli, Cristina Lo Celso
Nature Communications.2020;[Epub] CrossRef Targeting CXCR4 in AML and ALL
Daniel Cancilla, Michael P. Rettig, John F. DiPersio
Frontiers in Oncology.2020;[Epub] CrossRef Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies
Harinad Maganti, Alissa Visram, Risa Shorr, Jill Fulcher, Mitchell Sabloff, David S. Allan
Leukemia Research.2020; 97: 106442. CrossRef Chemokine receptor CXCR4: An important player affecting the molecular-targeted drugs commonly used in hematological malignancies
Liangliang Li, Ye Chai, ChongYang Wu, Li Zhao
Expert Review of Hematology.2020; 13(12): 1387. CrossRef The Role of Bone Stem Cell Niches in Bone Metastasis
Roberto Tamma, Tiziana Annese, Domenico Ribatti
Applied Sciences.2020; 10(21): 7713. CrossRef Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis
Cong Lu, Jiang Zhu, Xiangjun Chen, Yanjie Hu, Wei Xie, Junxia Yao, Shiang Huang
Frontiers in Oncology.2020;[Epub] CrossRef 3D models of the bone marrow in health and disease: yesterday, today, and tomorrow
Annamarija Raic, Toufik Naolou, Anna Mohra, Chandralekha Chatterjee, Cornelia Lee-Thedieck
MRS Communications.2019; 9(1): 37. CrossRef Alteration of cellular and immune‐related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes
Nazli Jafarzadeh, Zohreh Safari, Majid Pornour, Naser Amirizadeh, Mehdi Forouzandeh Moghadam, Majid Sadeghizadeh
Journal of Cellular Physiology.2019; 234(4): 3697. CrossRef Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging
Delfim Duarte, Saoirse Amarteifio, Heather Ang, Isabella Y Kong, Nicola Ruivo, Gunnar Pruessner, Edwin D Hawkins, Cristina Lo Celso
Immunology & Cell Biology.2019; 97(2): 229. CrossRef Adhesion Deregulation in Acute Myeloid Leukaemia
Alicja M. Gruszka, Debora Valli, Cecilia Restelli, Myriam Alcalay
Cells.2019; 8(1): 66. CrossRef High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype
Håkon Reikvam, Elise Aasebø, Annette K. Brenner, Sushma Bartaula-Brevik, Ida Sofie Grønningsæter, Rakel Brendsdal Forthun, Randi Hovland, Øystein Bruserud
Journal of Clinical Medicine.2019; 8(7): 970. CrossRef The FLT3-ITD mutation and the expression of its downstream signaling intermediates STAT5 and Pim-1 are positively correlated with CXCR4 expression in patients with acute myeloid leukemia
Tingyong Cao, Nenggang Jiang, Hongyan Liao, Xiao Shuai, Jun Su, Qin Zheng
Scientific Reports.2019;[Epub] CrossRef Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis
Lane H. Miller, Cheng-Kui Qu, Melinda Pauly
Experimental Hematology.2018; 66: 17. CrossRef Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy
D. Brooke Widner, Sun H. Park, Matthew R. Eber, Yusuke Shiozawa
Current Osteoporosis Reports.2018; 16(5): 596. CrossRef Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
Michela Colombo, Leonardo Mirandola, Maurizio Chiriva-Internati, Andrea Basile, Massimo Locati, Elena Lesma, Raffaella Chiaramonte, Natalia Platonova
Frontiers in Immunology.2018;[Epub] CrossRef Pathological roles of the homeostatic chemokine CXCL12
Rik Janssens, Sofie Struyf, Paul Proost
Cytokine & Growth Factor Reviews.2018; 44: 51. CrossRef Detection of high serum concentration of CXC chemokine ligand-12 in acute intracerebral hemorrhage
Jia Shen, Bin Chen, Guan-Rong Zheng, Shen-Zhong Qiu, Huai-Ming Yin, Wei Mao, Hong-Xiang Wang, Jian-Bo Gao
Clinica Chimica Acta.2017; 471: 55. CrossRef The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation
Chang Dong Yeo, Nahyeon Kang, Su Yeon Choi, Bit Na Kim, Chan Kwon Park, Jin Woo Kim, Young Kyoon Kim, Seung Joon Kim
The Korean Journal of Internal Medicine.2017; 32(4): 589. CrossRef
|